Surgeries & Interventions

Interventional Cardiology Joins The Match for 2025

Prospective interventional cardiology fellows can breathe a sigh of relief. Starting in 2025, three-quarters of interventional cardiology fellowship programs will transition to a voluntary match system.

“The Match” uses an algorithm to place resident and fellowship applicants into their most preferred programs that also prefer them. 

  • While all other CV specialty fellowships already use a match system to place candidates, IC has been the lone exception. That will change in the 2024-2025 application cycle. 

The Society for Cardiovascular Angiography and Interventions (SCAI) initiated the change, hoping that the match system will promote “fairness, equity, and thoughtfulness.” 

  • Of the 177 accredited IC training programs, 136 signed on to SCAI’s initiative in support of the match– just surpassing the 75% threshold needed to change the precedent.

The current system, which will be phased out in 2024, can be chaotic and anxiety-inducing for applicants. There is no central information hub to find out key details about available programs and positions, which prompts both the applicants and programs to waste a lot of effort.

  • When a candidate is offered a position, they have a certain amount of time to either accept or decline the offer – sometimes as little as 48 hours – and often don’t have the opportunity to complete interviews at other institutions. Cardiologists have made it clear that they hate this. 

The Takeaway

The Match should help shift the decision-making power in favor of the candidate, rather than the program. In the next couple of years, candidates will have the opportunity to interview and assess the programs that might best meet their professional, personal, and logistic objectives without the pressure of an unreasonable deadline to commit.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

Cardiology Pharmaceuticals August 18, 2025

Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025

New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups. The Post Hoc AFIRE Analysis examined 2,215 Japanese patients with AFib and stable CAD, stratifying them into four age groups (<70, 70-74, 75-79, and […]

Surgeries & Interventions August 14, 2025

TEER Could Save Lives in AFMR Patients August 14, 2025

Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR). The new OCEAN-Mitral/REVEAL-AFMR Analysis compared 441 TEER-treated patients against 640 medically managed controls with moderate or severe atrial FMR, stating a solid case […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!